Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Clinical trial NCT03013998 · RECRUITING

Trial details

NCT number: NCT03013998
Sponsor: Beat AML, LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Previously Untreated Relapsed Refractory Acute Myeloid Leukemia

Start date: 2016-11-01
Primary completion: 2028-12-01
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.